Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post hoc power analysis: an idea whose time has passed?

M Levine1, M H Ensom

  • 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, Canada.

Pharmacotherapy
|April 20, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A study of the pharmacokinetic profile of low-dose hepatitis B immune globulin in long-term liver transplant recipients for chronic hepatitis B infection.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2002
Same author

Evaluation of droperidol in the acutely agitated child or adolescent.

Canadian journal of psychiatry. Revue canadienne de psychiatrie·2002
Same author

Pharmacogenetics: the therapeutic drug monitoring of the future?

Clinical pharmacokinetics·2001
Same author

Pharmacokinetics of fluconazole in trauma patients with postpyloric feeding tubes.

The Annals of pharmacotherapy·2001
Same author

A limited sampling strategy for cyclosporine area under the curve monitoring in lung transplant recipients.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2001
Same author

Role of therapeutic drug monitoring for protease inhibitors.

The Annals of pharmacotherapy·2001
Same journal

Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

Response to Comment on "Pharmacokinetic Analysis of Intravenous Push Cefepime in Critically Ill Patients With Sepsis".

Pharmacotherapy·2026
Same journal

The Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single Oral Dose of Zongertinib in Healthy Male Volunteers.

Pharmacotherapy·2026
Same journal

Menopausal Hormone Therapy: A Narrative Review of Contemporary Evidence.

Pharmacotherapy·2026
Same journal

Getting It Right the Second Time: How Can we Optimize First-Generation Cephalosporin Dosing for Skin and Soft Tissue Infections in the 21st Century?

Pharmacotherapy·2026
Same journal

Buprenorphine Initiation During Extracorporeal Membrane Oxygenation Decreases Sedative and Opioid Exposure: A Retrospective Matched Case-Control Study.

Pharmacotherapy·2026
See all related articles

Post hoc analyses can mislead readers of negative clinical trial results. Confidence intervals offer a clearer interpretation of trial data and sample size adequacy compared to post hoc power calculations.

Area of Science:

  • Clinical Trials
  • Statistical Analysis
  • Medical Research

Background:

  • Authors often face challenges when submitting manuscripts reporting negative clinical trial results.
  • Post hoc analyses are frequently used but can lead to misinterpretations.
  • Interpreting the adequacy of sample size in clinical trials is crucial for valid conclusions.

Purpose of the Study:

  • To illustrate the potential pitfalls of post hoc analysis in the context of negative clinical trials.
  • To demonstrate the utility of confidence intervals for interpreting clinical trial outcomes.
  • To compare the effectiveness of confidence intervals versus post hoc power calculations in assessing sample size adequacy.

Main Methods:

  • A hypothetical scenario simulating author experiences with negative clinical trial submissions was developed.

Related Experiment Videos

  • This scenario was used to explain the application of confidence intervals in interpreting clinical trial results.
  • Post hoc power calculations were also considered within the same scenario for comparison.

    • Main Results:

    • The hypothetical scenario highlighted how post hoc analyses can obscure or misrepresent findings from negative clinical trials.
    • Confidence intervals were shown to provide a more robust method for interpreting the precision of estimates.
    • Confidence intervals more effectively indicated the possibility of an inadequate sample size compared to post hoc power calculations.

    Conclusions:

    • Confidence intervals are a superior tool for interpreting results of clinical trials, particularly those with negative findings.
    • Reliance on post hoc analyses can lead to erroneous conclusions about treatment effects and study validity.
    • Researchers should prioritize the use and understanding of confidence intervals to accurately assess clinical trial outcomes and sample size limitations.